Growth Metrics

Elanco Animal Health (ELAN) EBIT Margin: 2017-2025

Historic EBIT Margin for Elanco Animal Health (ELAN) over the last 8 years, with Sep 2025 value amounting to 14.69%.

  • Elanco Animal Health's EBIT Margin rose 818.00% to 14.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.85%, marking a year-over-year increase of 3791.00%. This contributed to the annual value of -34.13% for FY2024, which is 3664.00% up from last year.
  • Per Elanco Animal Health's latest filing, its EBIT Margin stood at 14.69% for Q3 2025, which was down 17.52% from 17.81% recorded in Q2 2025.
  • Elanco Animal Health's EBIT Margin's 5-year high stood at 20.87% during Q1 2025, with a 5-year trough of -148.31% in Q3 2023.
  • For the 3-year period, Elanco Animal Health's EBIT Margin averaged around -33.65%, with its median value being -41.74% (2024).
  • Its EBIT Margin has fluctuated over the past 5 years, first tumbled by 9,802bps in 2023, then soared by 15,482bps in 2024.
  • Over the past 5 years, Elanco Animal Health's EBIT Margin (Quarterly) stood at -57.10% in 2021, then soared by 259bps to -54.52% in 2022, then crashed by 761bps to -62.13% in 2023, then spiked by 801bps to -54.12% in 2024, then soared by 818bps to 14.69% in 2025.
  • Its EBIT Margin stands at 14.69% for Q3 2025, versus 17.81% for Q2 2025 and 20.87% for Q1 2025.